DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+2.63%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.81B
AUM Growth
+$1.81B
(-30%)
Cap. Flow
-$568M
Cap. Flow
% of AUM
-31.37%
Top 10 Holdings %
Top 10 Hldgs %
42.89%
Holding
116
New
9
Increased
14
Reduced
41
Closed
26
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$33.2M |
| 2 |
Glaukos
GKOS
|
$29.6M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$20.1M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
$18.5M |
| 5 |
McKesson
MCK
|
$14.2M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$58.9M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$58M |
| 3 |
Elevance Health
ELV
|
$45.7M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$40.3M |
| 5 |
Centene
CNC
|
$38.7M |
Sector Composition
| 1 | Healthcare | 74.5% |
| 2 | Financials | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
26
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $15.9M | 0.85% |
945,710
+329,202
| +53% | +$5.54M |
|
|
AAAP
27
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $15.3M | 0.82% |
392,904
-130,119
| -25% | -$5.08M |
|
28
Galapagos
GLPG
$2.06B
| $14.3M | 0.77% |
187,501
-72,267
| -28% | -$5.53M |
|
|
29
Elevance Health
ELV
$72.4B
| $14.1M | 0.75% |
75,182
-242,818
| -76% | -$45.7M |
|
30
Wave Life Sciences
WVE
$1.27B
| $13.9M | 0.74% |
746,841
+274,717
| +58% | +$5.11M |
|
|
AAC
31
DELISTED
AAC Holdings, Inc.
AAC
| $13.7M | 0.73% |
1,975,347
| – | – |
|
|
SCTL
32
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $13.4M | 0.71% |
2,120,379
-193,246
| -8% | -$1.22M |
|
33
AnaptysBio
ANAB
$630M
| $13.2M | 0.71% |
552,859
-292,887
| -35% | -$7.01M |
|
34
eHealth
EHTH
$126M
| $13M | 0.69% |
690,348
-1,950,261
| -74% | -$36.7M |
|
35
Xencor
XNCR
$594M
| $11.9M | 0.63% |
562,236
-722,522
| -56% | -$15.3M |
|
36
CytomX Therapeutics
CTMX
$350M
| $11.7M | 0.63% |
756,822
-186,611
| -20% | -$2.89M |
|
37
Ascendis Pharma
ASND
$12.1B
| $11.6M | 0.62% |
419,453
-509,773
| -55% | -$14.2M |
|
38
Ardelyx
ARDX
$1.57B
| $11.6M | 0.62% |
2,279,780
+1,438,036
| +171% | +$7.33M |
|
39
Axogen
AXGN
$718M
| $11.3M | 0.6% |
674,428
-1,163,797
| -63% | -$19.5M |
|
40
argenx
ARGX
$44.2B
| $10.8M | 0.58% |
+509,022
| New | +$10.8M |
|
|
NEOS
41
DELISTED
Neos Therapeutics, Inc
NEOS
| $10.7M | 0.57% |
1,459,195
-639,971
| -30% | -$4.67M |
|
42
Molina Healthcare
MOH
$9.6B
| $10.5M | 0.56% |
+151,665
| New | +$10.5M |
|
|
BPMC
43
DELISTED
Blueprint Medicines
BPMC
| $10.3M | 0.55% |
203,000
-1,162,000
| -85% | -$58.9M |
|
44
Aclaris Therapeutics
ACRS
$223M
| $10.2M | 0.54% |
375,000
| – | – |
|
|
EPZM
45
DELISTED
Epizyme, Inc
EPZM
| $10M | 0.53% |
662,369
-751,227
| -53% | -$11.3M |
|
46
Sangamo Therapeutics
SGMO
$161M
| $9.63M | 0.51% |
1,094,305
+256,342
| +31% | +$2.26M |
|
|
47
Centene
CNC
$14.8B
| $9.51M | 0.51% |
238,000
-969,286
| -80% | -$38.7M |
|
|
STDY
48
DELISTED
SteadyMed Ltd
STDY
| $9.08M | 0.48% |
1,441,913
-314,457
| -18% | -$1.98M |
|
|
ALPN
49
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $9M | 0.48% |
933,103
| – | – |
|
|
IVTY
50
DELISTED
Invuity, Inc
IVTY
| $8.54M | 0.46% |
1,177,229
-513,269
| -30% | -$3.72M |
|